These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 17199967)

  • 1. Cardiac ryanodine receptor gene (hRyR2) mutation underlying catecholaminergic polymorphic ventricular tachycardia in a Chinese adolescent presenting with sudden cardiac arrest and cardiac syncope.
    Mok NS; Lam CW; Fong NC; Hui YW; Choi YC; Chan KY
    Chin Med J (Engl); 2006 Dec; 119(24):2129-33. PubMed ID: 17199967
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia.
    Hayashi M; Denjoy I; Extramiana F; Maltret A; Buisson NR; Lupoglazoff JM; Klug D; Hayashi M; Takatsuki S; Villain E; Kamblock J; Messali A; Guicheney P; Lunardi J; Leenhardt A
    Circulation; 2009 May; 119(18):2426-34. PubMed ID: 19398665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catecholaminergic polymorphic ventricular tachycardia caused by a novel mutation in the cardiac ryanodine receptor.
    Hasdemir C; Aydin HH; Sahin S; Wollnik B
    Anadolu Kardiyol Derg; 2008 Oct; 8(5):E35-6. PubMed ID: 18849218
    [No Abstract]   [Full Text] [Related]  

  • 4. Unusual clinical presentation in a family with catecholaminergic polymorphic ventricular tachycardia due to a G14876A ryanodine receptor gene mutation.
    Allouis M; Probst V; Jaafar P; Schott JJ; Le Marec H
    Am J Cardiol; 2005 Mar; 95(5):700-2. PubMed ID: 15721128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of catecholaminergic polymorphic ventricular tachycardia caused by two calsequestrin 2 mutations.
    de la Fuente S; Van Langen IM; Postma AV; Bikker H; Meijer A
    Pacing Clin Electrophysiol; 2008 Jul; 31(7):916-9. PubMed ID: 18684293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are there juvenile and adult types in patients with catecholaminergic polymorphic ventricular tachycardia?
    Sumitomo N
    Heart Rhythm; 2011 Jun; 8(6):872-3. PubMed ID: 21338709
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel mutation (Arg169Gln) of the cardiac ryanodine receptor gene causing exercise-induced bidirectional ventricular tachycardia.
    Hsueh CH; Weng YC; Chen CY; Lin TK; Lin YH; Lai LP; Lin JL
    Int J Cardiol; 2006 Apr; 108(2):276-8. PubMed ID: 16517285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Catecholinergic ventricular tachycardia in children].
    Denjoy I; Postma A; Lupoglazoff JM; Vaksman G; Kamblock J; Leenhardt A; Wilde AA; Guicheney P
    Arch Mal Coeur Vaiss; 2005 May; 98(5):506-12. PubMed ID: 15966600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation in FKBP12.6 binding region of the human cardiac ryanodine receptor gene (R2401H) in a Japanese patient with catecholaminergic polymorphic ventricular tachycardia.
    Aizawa Y; Ueda K; Komura S; Washizuka T; Chinushi M; Inagaki N; Matsumoto Y; Hayashi T; Takahashi M; Nakano N; Yasunami M; Kimura A; Hiraoka M; Aizawa Y
    Int J Cardiol; 2005 Mar; 99(2):343-5. PubMed ID: 15749201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ryanodine receptor (RyR2) mutations in sudden cardiac death: studies in extended pedigrees and phenotypic characterization in vitro.
    Marjamaa A; Laitinen-Forsblom P; Wronska A; Toivonen L; Kontula K; Swan H
    Int J Cardiol; 2011 Mar; 147(2):246-52. PubMed ID: 19781797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia.
    Sy RW; Gollob MH; Klein GJ; Yee R; Skanes AC; Gula LJ; Leong-Sit P; Gow RM; Green MS; Birnie DH; Krahn AD
    Heart Rhythm; 2011 Jun; 8(6):864-71. PubMed ID: 21315846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Description of a novel RyR2 mutation in a juvenile patient with symptomatic catecholaminergic polymorphic ventricular tachycardia in sleep and during exercise: a case report.
    Seidlmayer LK; Riediger F; Pagonas N; Nordbeck P; Ritter O; Sasko B
    J Med Case Rep; 2018 Oct; 12(1):298. PubMed ID: 30296944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catecholaminergic polymorphic ventricular tachycardia found in an adolescent after a methylenedioxymethamphetamine and marijuana-induced cardiac arrest.
    Diffley M; Armenian P; Gerona R; Reinhartz O; Avasarala K
    Crit Care Med; 2012 Jul; 40(7):2223-6. PubMed ID: 22584762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients.
    Postma AV; Denjoy I; Kamblock J; Alders M; Lupoglazoff JM; Vaksmann G; Dubosq-Bidot L; Sebillon P; Mannens MM; Guicheney P; Wilde AA
    J Med Genet; 2005 Nov; 42(11):863-70. PubMed ID: 16272262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deadly proposal: a case of catecholaminergic polymorphic ventricular tachycardia.
    Heiner JD; Bullard-Berent JH; Inbar S
    Pediatr Emerg Care; 2011 Nov; 27(11):1065-8. PubMed ID: 22068070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular basis of catecholaminergic polymorphic ventricular tachycardia: what are the different hypotheses regarding mechanisms?
    Wehrens XH
    Heart Rhythm; 2007 Jun; 4(6):794-7. PubMed ID: 17556207
    [No Abstract]   [Full Text] [Related]  

  • 17. Emotional stress and sudden death--the role of cathecholaminergic polymorphic ventricular tachycardia.
    Iyer HV
    Eur J Intern Med; 2009 Dec; 20(8):e160. PubMed ID: 19892298
    [No Abstract]   [Full Text] [Related]  

  • 18. Catecholaminergic polymorphic ventricular tachycardia in a child: a case report.
    Garabedian L; Verryckt A; Panzer J; De Wolf D
    Acta Paediatr; 2008 Jan; 97(1):127-9. PubMed ID: 18052993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Not all sudden death is the same.
    Allen PD
    Circ Res; 2003 Sep; 93(6):484-6. PubMed ID: 14500330
    [No Abstract]   [Full Text] [Related]  

  • 20. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia.
    Priori SG; Napolitano C; Tiso N; Memmi M; Vignati G; Bloise R; Sorrentino V; Danieli GA
    Circulation; 2001 Jan; 103(2):196-200. PubMed ID: 11208676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.